Author

K. Stamatakis

Goethe University Frankfurt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

A. Jimenez-Segovia· 1 shared A. Mota· 1 shared A. Rojo-Sebastian· 1 shared A. Rynne-Vidal· 1 shared Andreas WalbruniD· 1 shared Asger Givskov JørgenseniD· 1 shared B. Barrocal· 1 shared Beatrix SuessiD· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Jimenez-Segovia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A unique mechanism explaining the outstanding performance of a newly discovered doxycycline riboswitch

Janis Hoetzel, Andreas Walbrun, M. Schäfer, T. Wang, Asger Givskov Jørgensen, K. Stamatakis, Vincent J. Gunawan, O. Becker, L. Reichardt, Leon Boettger, Robin Werner Bruckhoff, Jørgen Kjems, Josef Wachtveitl, Matthias Rief, Beatrix Suess

The paper identifies a doxycycline-binding aptamer with exceptional regulatory properties in yeast and human cells, revealing a unique structural mechanism and validating its effectiveness through experimental methods.

bioRxiv · Nov 11, 2025 · PreprintMolecular Biology

Prostaglandin F2α-induced TGFβ-PMEPA1 pathway is a critical mediator of epithelial plasticity and ovarian carcinoma progression.

A. Jimenez-Segovia, A. Mota, A. Rojo-Sebastian, B. Barrocal, A. Rynne-Vidal, M. L. Garcia-Bermejo, R. Gomez-Bris, L. J. A. C. Hawinkels, P. Sandoval, R. Garcia-Escudero, M. Lopez-Cabrera, G. Moreno-Bueno, M. Fresno, K. Stamatakis

This paper identifies PGF2α-induced TGFβ-PMEPA1 pathway as a driver of epithelial plasticity and ovarian cancer progression, with PMEPA1 as a therapeutic target and prognostic biomarker.

bioRxiv · Sep 18, 2018Cancer Biology